趋化因子
败血症
脂多糖
促炎细胞因子
趋化性
炎症
免疫学
小RNA
巨噬细胞
激酶
细胞生物学
下调和上调
癌症研究
化学
生物
受体
基因
体外
生物化学
作者
Chun Wang,Yuxuan Zheng,Qingting Fan,Zilüe Li,Xin Qi,Fanyan Chen,Lei Xu,Sha Zhou,Xiaojun Chen,Yalin Li,Jifeng Zhu,Chuan Su
出处
期刊:Shock
[Ovid Technologies (Wolters Kluwer)]
日期:2023-10-02
卷期号:61 (4): 611-619
被引量:4
标识
DOI:10.1097/shk.0000000000002236
摘要
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Macrophages play important roles in the inflammatory process of sepsis by secreting chemokines. Chemokine (CC-motif) ligand 2 (CCL-2) is one of the main proinflammatory chemokines secreted by macrophages that plays a critical role in the recruitment of more monocytes and macrophages to the sites of injury in sepsis, but the mechanisms that regulate CCL-2 expression in macrophages during sepsis are still unknown. In the present study, by using the LPS-induced endotoxemia model, we found that LPS induced the expression of microRNA (miR)-155 and CCL-2 in endotoxemic mice and RAW264.7 cells. MiR-155 mimics or miR-155 inhibitor treatment experiment suggested that miR-155 was sufficient to increase LPS-induced CCL-2 expression in macrophages, but miR-155 was not the only factor promoting CCL-2 expression. We further demonstrated that miR-155-induced increase of CCL-2 promoted chemotaxis of additional macrophages, which subsequently enhanced lung injury in endotoxemic mice. Serum/glucocorticoid regulated kinase family member 3 (SGK3), a potential target of miR-155, was identified by RNA sequencing and predicted by TargetScan and miRDB. We further confirmed miR-155 regulated SGK3 to increase LPS-induced CCL-2 by using miR-155 mimics and SGK3 overexpression. Thus, our study demonstrates that miR-155 targets SGK3 to increase LPS-induced CCL-2 expression in macrophages, which promotes macrophage chemotaxis and enhances organs injury during endotoxemia. Our study contributed to a better understanding of the mechanisms underlying the inflammatory response during sepsis.
科研通智能强力驱动
Strongly Powered by AbleSci AI